Could a common diabetes pill stop prediabetes in its tracks?
NCT ID NCT06828731
Summary
This study tested if a medication called empagliflozin, which is already used for diabetes, could help people with prediabetes. The goal was to see if it could slow or prevent the progression to full diabetes and reduce future heart and kidney risks. For 12 weeks, 60 veterans with prediabetes either took the drug or were in a control group, while researchers measured blood sugar, weight, and other health markers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charles George VA Medical Center
Asheville, North Carolina, 28805, United States
Conditions
Explore the condition pages connected to this study.